* Jaguar Health Inc JAGX.OQ reported a quarterly adjusted
loss
of 40 cents per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 17
cents per share.
* Revenue rose 111.5% to $2.63 million from a year ago;
analysts
expected $1.62 million.
* Jaguar Health Inc's reported EPS for the quarter was a
loss
of 40 cents.
* The mean earnings estimate of analysts had risen by
about 16.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Jaguar Health Inc shares had fallen by 43.6% this
quarter and
lost 61.5% so far this year.
* The company reported a quarterly loss of $17.99 million.
* Wall Street's median 12-month price target for Jaguar
Health Inc
is $10.88
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated May 11 at 05:15 p.m. All
figures in US dollars unless otherwise stated